- Home
- AMPY vs FENC Comparison
AMPY vs FENC Comparison
Compare AMPY & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMPY | FENC |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.9M | 230.8M |
| IPO Year | 2011 | 2010 |
Fundamental Metrics
Financial Performance| Metric | AMPY | FENC |
|---|---|---|
| Price | $3.99 | $10.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | ★ 942.0K | 259.7K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 232.26 | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $208,637,000.00 | $44,642,000.00 |
| Revenue This Year | N/A | $65.12 |
| Revenue Next Year | $23.83 | $41.08 |
| P/E Ratio | ★ N/A | $1,034.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.12 | $5.65 |
| 52 Week High | $6.79 | $11.31 |
Technical Indicators
Market Signals| Indicator | AMPY | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 35.74 | 64.96 |
| Support Level | $3.86 | $7.40 |
| Resistance Level | $4.92 | N/A |
| Average True Range (ATR) | 0.15 | 0.50 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 27.64 | 73.79 |
Price Performance
Historical ComparisonAbout AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.